Research Topic

Sphingolipid Metabolism and Cancer

About this Research Topic

Sphingolipid metabolism plays an essential role in the functional integrity of the nervous system, immune activation, inflammatory response, cardiac and kidney functions. Alteration in the metabolism of sphingolipids links to a group of rare genetic diseases caused by a defect in lysosomal sphingolipid degradation. A majority of sphingolipids disorders, including lysosomal storage disorders, are associated with neurodegenerative processes, metabolic and proliferative disorders. However, the occurrence of cancer among patients with lysosomal storage disorders was never systematically examined, except for type 1 Gaucher disease, where risk of developing hematological malignancies was recognized.

Overall, bioactive sphingolipids play a crucial role in major aspects of cell signaling pathways, including autophagy-lysosomal signaling pathway, cell cycle, apoptosis, cell migration, endocytosis, and mitochondrial metabolism. Recently, sphingolipids are receiving increasing attention as contributors to cancer progression and responders to chemotherapy. It has been demonstrated that many types of tumors display dysregulation of sphingolipid metabolism. If so, understanding sphingolipid metabolism becomes important in the clinic for development of novel therapies and diagnostics of cancer.

This Research Topic focuses on functional disruption of sphingolipid metabolism in cancer pathology and a review of novel therapeutic agents targeting sphingolipid metabolism. Additionally, the topic includes prediction of cancer risk and cancer therapy for patients with sphingolipid disorders.

We welcome the submission of original research, clinical trials, clinical cases and reviews. We also encourage undergraduate and graduate students and postdoctoral trainees to write reviews with mentors, focusing on, but not limited to the following subtopics:

1. Sphingolipids metabolism and cancer progression.
2. Targeting sphingolipid metabolism as an approach for cancer therapy.
3. Small-molecules and inhibitors that target sphingolipid metabolism as a therapy for brain cancer.
4. Sphingolipid metabolism disorders and cancer.

Note: manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.


Keywords: Sphingolipids, Cancer Metabolism, Cancer Therapy, Brain Cancer, Sphingolipid Metabolism


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Sphingolipid metabolism plays an essential role in the functional integrity of the nervous system, immune activation, inflammatory response, cardiac and kidney functions. Alteration in the metabolism of sphingolipids links to a group of rare genetic diseases caused by a defect in lysosomal sphingolipid degradation. A majority of sphingolipids disorders, including lysosomal storage disorders, are associated with neurodegenerative processes, metabolic and proliferative disorders. However, the occurrence of cancer among patients with lysosomal storage disorders was never systematically examined, except for type 1 Gaucher disease, where risk of developing hematological malignancies was recognized.

Overall, bioactive sphingolipids play a crucial role in major aspects of cell signaling pathways, including autophagy-lysosomal signaling pathway, cell cycle, apoptosis, cell migration, endocytosis, and mitochondrial metabolism. Recently, sphingolipids are receiving increasing attention as contributors to cancer progression and responders to chemotherapy. It has been demonstrated that many types of tumors display dysregulation of sphingolipid metabolism. If so, understanding sphingolipid metabolism becomes important in the clinic for development of novel therapies and diagnostics of cancer.

This Research Topic focuses on functional disruption of sphingolipid metabolism in cancer pathology and a review of novel therapeutic agents targeting sphingolipid metabolism. Additionally, the topic includes prediction of cancer risk and cancer therapy for patients with sphingolipid disorders.

We welcome the submission of original research, clinical trials, clinical cases and reviews. We also encourage undergraduate and graduate students and postdoctoral trainees to write reviews with mentors, focusing on, but not limited to the following subtopics:

1. Sphingolipids metabolism and cancer progression.
2. Targeting sphingolipid metabolism as an approach for cancer therapy.
3. Small-molecules and inhibitors that target sphingolipid metabolism as a therapy for brain cancer.
4. Sphingolipid metabolism disorders and cancer.

Note: manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.


Keywords: Sphingolipids, Cancer Metabolism, Cancer Therapy, Brain Cancer, Sphingolipid Metabolism


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

31 August 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

31 August 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..